Cameron John Reynolds - 05 Aug 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: President and CEO, Director
Signature: /s/ Cameron John Reynolds
Issuer symbol: VNRX
Transactions as of: 05 Aug 2025
Net transactions value: +$50,000
Form type: 4
Filing time: 06 Aug 2025, 09:00:10 UTC
Previous filing: 25 Jul 2025
Next filing: 15 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Reynolds Cameron John	President and CEO, Director	1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON	/s/ Cameron John Reynolds	06 Aug 2025	0001340610

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Purchase	$50,000	+78,125	+3.1%	$0.6400	2,609,847	05 Aug 2025	Direct	F1
holding	VNRX	Common Stock						1,007,718	05 Aug 2025	By Concord International, Inc.	F2
holding	VNRX	Common Stock						34,076	05 Aug 2025	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
F2	The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.